Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Short

Showing results (651-660 of 659) with videos related to

Pageof 66
Sort By:
You have reached the last page of results.This site can display upto 659 results.
Leukemia|March 6, 2026
Performance of molecular scoring systems in hypomethylating agent-treated myelodysplastic neoplasmsKelly S Chien, Ziyi Li, Luca Lanino, et al.
Leukemia|February 25, 2025
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemiaCourtney D DiNardo, Wei-Ying Jen, Koichi Takahashi, et al.
Leukemia|December 10, 2025
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemiaCourtney D DiNardo, Wei-Ying Jen, Koichi Takahashi, et al.
The Lancet. Haematology|September 8, 2020
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trialCourtney D DiNardo, Abhishek Maiti, Caitlin R Rausch, et al.
Blood Cancer Discovery|January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Nature Cancer|September 19, 2024
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analysesCourtney D DiNardo, Divij Verma, Natalia Baran, et al.
Kidney International|December 14, 2023
Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosisTereza Kmochová, Kendrah O Kidd, Andrew Orr, et al.
Leukemia|August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international communityBranko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Nature Genetics|May 21, 2025
Genome-wide association study of long COVIDVilma Lammi, Tomoko Nakanishi, Samuel E Jones, et al.
Pageof 66

Showing results (651-660 of 659) with videos related to

Sort By:
Pageof 66
You have reached the last page of results.This site can display upto 659 results.
Leukemia|March 6, 2026
Performance of molecular scoring systems in hypomethylating agent-treated myelodysplastic neoplasmsKelly S Chien, Ziyi Li, Luca Lanino, et al.
Leukemia|February 25, 2025
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemiaCourtney D DiNardo, Wei-Ying Jen, Koichi Takahashi, et al.
Leukemia|December 10, 2025
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemiaCourtney D DiNardo, Wei-Ying Jen, Koichi Takahashi, et al.
The Lancet. Haematology|September 8, 2020
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trialCourtney D DiNardo, Abhishek Maiti, Caitlin R Rausch, et al.
Blood Cancer Discovery|January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Nature Cancer|September 19, 2024
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analysesCourtney D DiNardo, Divij Verma, Natalia Baran, et al.
Kidney International|December 14, 2023
Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosisTereza Kmochová, Kendrah O Kidd, Andrew Orr, et al.
Leukemia|August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international communityBranko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Nature Genetics|May 21, 2025
Genome-wide association study of long COVIDVilma Lammi, Tomoko Nakanishi, Samuel E Jones, et al.
Pageof 66